100sek
-6,1 %
Date:2025-08-01Time:18:00:00Latest report:Q2-2025List:First NorthTicker:PROGEN
Market Cap:37 msekEnterprise Value:24 msekNet Sales:0,33 msekEarnings:-45,3 msekEmployees:0ISIN:SE0023261532

Ratios

10-year key figure history for Prostatype Genomics turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Prostatype Genomics with index and moving average MA50 and MA200.

Stockprice:1,00
MA50:1,16
MA200:5,72
Price/MA200:-82,5 %
RSI (14):47,8
Price/MA50:-13,5 %

Description

Prostatype Genomics operates in the medical technology sector. The company specializes in the development of medical genetic tests used for the identification, analysis and further follow-up of prostate cancer. In addition to its main business, related ancillary services are also offered. The business is operated globally with the largest presence in the Nordic market. The head office is located in Nacka Strand.

Pharmaceuticals